Mycoplasma orale

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Mycoplasma orale
Scientific classification edit
Domain: Bacteria
Phylum: Tenericutes
Class: Mollicutes
Order: Mycoplasmatales
Family: Mycoplasmataceae
Genus: Mycoplasma
M. orale
Binomial name
Mycoplasma orale
Taylor-Robinson et al. 1964

Mycoplasma orale is a small bacterium found in the class Mollicutes.[1] It belongs to the genus Mycoplasma, a well-known group of obligate intracellular parasites that inhabit humans.[2] It also is known to be an opportunistic pathogen in immunocompromised humans.[3] As with other Mycoplasma species, M. orale is not readily treated with many antibiotics due to its lack of a peptidoglycan cell wall.[4] Therefore, this species is relevant to the medical field as physicians face the task of treating patients suffering from infections with this microbe. It is characterized by a small physical size (0.1 micrometer in diameter on average), a small genome size, and a limited metabolism.[4][5][2] It is also known to frequently contaminate laboratory experiments.[5] This bacteria is very similar physiologically and morphologically to its sister species within the genus Mycoplasma; however, its recent discovery leaves many questions still unanswered about this microbe.

Discovery and isolation[edit]

Taylor-Robinson et al. identified and named M. orale in 1964 after isolating it from the oral cavity of a child at a Washington hospital and three servicemen stationed in North Carolina.[6] Taylor-Robinson et al. cultured the organism under anaerobic conditions on PPLO agar and broth.[6] The resulting colony growth had a "fried egg" appearance when cultured on solid PPLO agar.[6] PPLO is stands for "Pleuropneumonia-like organisms" and was originally designed for growth of parasitic bacteria found in the respiratory tract of cattle; it is now known that these bacteria were Mycoplasma species.[7] PPLO agar is used for isolation and growth of Mycoplasma and Ureaplasma species; it contains beef heart infusion, yeast extract, phenol red, sodium chloride, the antibiotic Polymyxin B, the antifungal Amphotericin B, the antibiotic Penicillin, deionized water, and horse serum.[7] Taylor-Robinson et al. confirmed M. orale was distinct from previously discovered Mycoplasma species with a serological test using haemagglutination of sheep erythrocytes, tannic acid and sonnicated Mycoplasma extracts.[6]

L.G. Tallgren et al. also isolated M. orale in 1974 from a sample of bone marrow taken from a three-year-old boy suffering from Eosinophilic leukaemia.[8] The sample was obtained via a bone marrow biopsy performed at Aurora Hospital in Helsinki, Finland.[8] L.G. Tallgren et al. noted this organism had a typical Mycoplasma "fried egg" appearance when cultured on solid media.[8]

Taxonomic and phylogenetic classification[edit]

As determined by 16S rRNA sequencing, M. orale is a bacterium belonging to the genus Mycoplasma.[2] Its closest relative within the genus is M. salivarius, while its most distant is M. mycoides.[2] M. orale and M. salivarius have both been observed in the human oral cavity, evidencing their close proximity in the genus Mycoplasma.[5]

Of the over 100 documented species in the genus Mycoplasma, 14 are known pathogens to humans.[1] This comes as no surprise, as the class Mollicutes contains common commensals or pathogens of several different organisms.[1] Many species in the genus Mycoplasma are commonly found associated with pelvic or genital region infections including M. fermentans and M. hominis.[9] Other species in this genus are the causative agents of respiratory related infections; these species include the well-known Mycoplasma pneumoniae.[10] The family Mycoplastaceae includes the genera Mycoplasma and Ureaplasma.[11] Bacteria in the genus Ureaplasma are known commensals in humans and possess the enzyme Urease (catalyzes urea to carbon dioxide and ammonia).[11] Both Mycoplasma and Ureaplasma species can be grown on the same PPLO medium due to their similarities in metabolism and growth requirement.[7]

Parasitism and genomics[edit]

While the genome of M. orale itself has not been fully sequenced, information can be surmised from the sequence data of its close relatives.[12][2] Members of the genus Mycoplasma are known for their incredibly small genomes, with an average size of 0.6 Mb.[2][13] This is the smallest discovered self-replicating genome of all known prokaryotes.[2] This significantly reduced genome size is thought to be the result of the taxon's evolution into obligate parasites.[14] Mycoplasma species typically invade and adhere to host cells from which they obtain their nutrients, usually at the expense of the host.[5] All members of this genus, including M. orale, inhabit a wide range of mammalian hosts.[15] Though M. orale usually exists as a commensal in human oral cavities, it is an opputunistic pathogen and will cause illness in human hosts when conditions are right.[3] Due to their small genome size and parasitic lifecycle, they lack many non-essential biosynthetic pathways in their metabolism.[2] These include those for cell wall synthesis as well as purine synthesis.[2] These genomic characteristics make them a good model for the Minimal Genome Concept.[2] Mycoplasma members, including M. orale, also generally have a low G-C content compared to other bacteria.[16] Research has revealed that the 16S rRNA gene of M. orale is about 1,510 bp.[13]

Growth: metabolism and reproduction[edit]

As stated previously, M. orale is an obligate parasite found in humans and primates according to the GIDEON Guide of medically relevant bacteria.[15] This evolution into parasitism has resulted in the loss of many functional metabolic pathways.[9] Therefore, these organisms are unable to grow and reproduce in culture without the necessary nutrients and metabolites present in media.[17] M. orale is cultured using a special medium, the 1076b. SP4-Z MEDIUM.[12] This medium contains either glucose or arginine (but not both at the same time) as a carbon source; however, it does not contain yeast extract.[18] For exact information regarding all components of this medium see "DSMZ Medium" in External Links.[18] It is considered to be a mesophilic bacteria growing best at a temperature of 37 °C.[12] This is expected, as theoretically it should grow best at the basal temperatures of its host. This organism was also found to grow optimally at pH 6.0 and had phosphatase activity at .2 Ual/Mg of protein.[19] Unlike other Mycoplasmas, M. orale does not have the ability to ferment glucose.[6] It is also unable to aerobically reduce 2-3-5 triphenyl tetrazolium.[14] This demonstrated its close phylogenetic relationship to other Mycoplasma species which inhabit human hosts.[14] M. orale was observed to divide in two ways: by either binary fission or by forming mycelial filaments in colonies.[17] Binary fission was observed deeper within colony growth while mycelial growth was found to occur more toward the air interface.[17] Thus, it was inferred that mycelial growth is associated with aerobic conditions, while growth by binary fission is associated with a more anaerobic environment.[17]

Medical relevance[edit]

M. orale is considered to be a non-pathogenic commensal, especially in immunocompetent individuals.[3] However, abscesses containing M. orale have been noted in patients who are immunocompromised.[3] A study was conducted on bacterial samples taken from a 33-year-old immunocompromised male.[3] This individual presented with fever, increased weight loss, and shoulder pain among other pathologies.[3] Samples were obtained from the patient and grown on media for testing.[3] 16S rRNA sequencing was completed and revealed the culprit of the infection, M. orale.[3] This revealed the ability of this organism to cause pathology in humans.[3] Infections with Mycoplasma members, including M. orale, can be difficult to treat with antibiotics due to their lack of a cell wall.[4] This lack of peptidoglycan confers resistance to any antibiotics that may target its synthesis, including the commonly used penicillin and its derivatives as well as vancomycin.[20] This presents a challenge to physicians as they try to treat their patients suffering from bacterial Mycoplasma infections.[20]

Lab contamination[edit]

Mycoplama species are commonly found in labs as contaminants. Beginning in 1956 through the early 2000s, various organizations including Johns Hopkins, US Food and Drug Administration and the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) in Germany, among others, have reported varying degrees of Mycoplasma contamination ranging from 15%-70% of cell cultures.[5] Mycoplasma contaminations are problematic because they are difficult to prevent and negatively impact host cell growth.[5] Contamination is common due to their small physical size, lack of cell wall, and pleomorphism.[5] Pleomorphism is defined as an organism's ability to modify their shape and size as a response to changes in their environment.[21] Pleomorphism in Mycoplasma species allows bypassing of typical membrane filtration systems.[5] As previous stated, their lack of a cell wall prevents the use of antibiotics to inhibit unwanted cell growth on cultured media.[5] In addition to culture contamination, Mycoplasma contaminating cell cultures can have a negative effect on host cell growth by stealing nutrients from host cells.[5] M. orale has been found to inhibit host cell growth by outcompeting the host cell for arginine.[5] It is important to prevent contamination of Mycoplasma for reliable and accurate laboratory research results.[5]


  1. ^ a b c Tortoli, E. (2014). "Microbiological features and clinical relevance of new species of the genus Mycobacterium". Clinical Microbiology Reviews. 27 (4): 727–752. doi:10.1128/cmr.00035-14. PMC 4187642. PMID 25278573.
  2. ^ a b c d e f g h i j Chambaud, I.; Heilig, R.; Ferris, S.; Barbe, V.; Samson, D.; Galisson, F.; Moszer, I.; Dybvig, K.; Wroblewski, H.; Viari, A.; Rocha, E.P.C.; Blanchard, A (2001). "The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonis". Nucleic Acids Research. 29 (10): 2145–2153. doi:10.1093/nar/29.10.2145. PMC 55444.
  3. ^ a b c d e f g h i Paessler, Michelle; Levinson, Arnold; Patel, Jean Baldus; Schuster, Mindy; Minda, Melanie; Nachamkin, Irving (2002-10-01). "Disseminated Mycoplasma orale infection in a patient with common variable immunodeficiency syndrome". Diagnostic Microbiology and Infectious Disease. 44 (2): 201–204. doi:10.1016/S0732-8893(02)00429-7.
  4. ^ a b c Niederweis, M.; Danilchanka, O.; Huff, J.; Hoffman, C.; Engelhardt, H. (2010). "Mycobacterial outermembranes: in search of proteins". Trends in Microbiology. 18 (3): 109–116. doi:10.1016/j.tim.2009.12.005. PMC 2931330. PMID 20060722.
  5. ^ a b c d e f g h i j k l Olarerin-George, A. & Hogenesch, J. (2015). "Assessing the prevalence of mycoplasma contamination in cell culture via a survey of NCBI's RNA-seq archive". Nucleic Acids Research. 43 (5): 2535–2542. doi:10.1093/nar/gkv136. PMC 4357728. PMID 25712092.
  6. ^ a b c d e Taylor-Robinson, D.; Canchola, J.; Chanock, R. M. (1964). "A Newly Identified Oral Mycoplasma (M. orale) and its Relationship to other Human Mycoplasmas". American Journal of Hygiene. 80 (1): 135–148. doi:10.1093/oxfordjournals.aje.a120454.
  7. ^ a b c "PPLO (Mycoplasma) Media". Hardy Diagnostics.
  8. ^ a b c Tallgren, L.G.; Wegelius, R.; Andersson, L.C. & Jansson, E. (1974). "Eosiniphilic Leukaemia—Recovery of Mycoplasma Orale from the Bone Marrow". Acta Medica Scandinavica. 195 (1–2): 87–92. doi:10.1111/j.0954-6820.1974.tb08102.x. PMID 4522224.
  9. ^ a b Razin, S.; Baron, S. (1996). "Mycoplasmas". Chapter 37: Mycoplasmas. In Medical Microbiology, 4th edition. Galveston, TX: University of Texas Medical Branch at Galveston. ISBN 9780963117212.
  10. ^ "Mycoplasma pneumoniae". Center for Disease Control. Retrieved February 21, 2017.
  11. ^ a b Blanchard, A., Razin, S., Kenny, G. E., & Barile, M. F. (1988). "Characteristics of Ureaplasma urealyticum urease". Journal of Bacteriology. 170 (6): 2692–2697. doi:10.1128/jb.170.6.2692-2697.1988. PMC 211190. PMID 3131306.CS1 maint: multiple names: authors list (link)
  12. ^ a b c "BacDrive: Mycoplasma orale".
  13. ^ a b "AY796060 Sequence Browser - StrainInfo".
  14. ^ a b c Fox, H.; Purcell, R. H.; Chanock, R. M. (1969). "Characterization of a Newly Identified Mycoplasma (Mycoplasma orale Type 3) from the Human Oropharynx". Journal of Bacteriology. 98 (1): 36–43. PMC 249900. PMID 4976470.
  15. ^ a b Berger, Stephen (2014). GIDEON guide to medically important bacteria. Los Angeles, California: GIDEON Informatics Inc. ISBN 9781617558412.
  16. ^ Boxer, Linda Minium; Korn, David (1979). "Structural and enzymological characterization of the homogeneous deoxyribonucleic acid polymerase from Mycoplasma orale". Biochemistry. 18 (21): 4742–4749. doi:10.1021/bi00588a039. ISSN 0006-2960.
  17. ^ a b c d NAKAMURA, M. & KAWAGUCHI, M. (1972). "Ultrastructure of Mycoplasma orale Serotype 1 in Agar Growth". Journal of General Microbiology. 70 (2): 305–314. doi:10.1099/00221287-70-2-305. PMID 5038879.
  18. ^ a b "DSMZ Microorganisms. 1076b. SP4-Z MEDIUM" (PDF). DSMZ. Retrieved February 21, 2017.
  19. ^ Shibata, K.; Totsuka, M.; Watanabe, T. (1986). "Phosphatase Activity as a Criterion for Differentiation of Oral Mycoplasma". Journal of Clinical Microbiology. 23: 970–972.
  20. ^ a b Romaniuk, J. A. H.; Cegelski, L. (2015). "Bacterial cell wall composition and the influence of antibiotics by cell-wall and whole-cell NMR". Philosophical Transactions of the Royal Society B: Biological Sciences. 370 (1679): 20150024. doi:10.1098/rstb.2015.0024. PMC 4632600. PMID 26370936.
  21. ^ Joshi, Hiren M; Toleti, Rao S (2009-07-07). "Nutrition induced pleomorphism and budding mode of reproduction in Deinococcus radiodurans". BMC Research Notes. 2: 123. doi:10.1186/1756-0500-2-123. ISSN 1756-0500. PMC 2714317. PMID 19583846.

External links[edit]